A propensity analysis of AURORA 1 suggested that initial therapy with LUPKYNIS® plus standard of care improved safety and demonstrated earlier reductions in proteinuria when compared to a conventional regimen consisting of higher doses of both mycophen
PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced the sale of portions of financial
WINNIPEG, Manitoba--(BUSINESS WIRE)--Ag Growth International Inc. (TSX: AFN) (“AGI”, the “Company”, “we” or “our”) today announced its financial results for the three-months ended September 30, 2023. Third Quarter 2023 Highlights Revenue1
HOUSTON--(BUSINESS WIRE)--DXP Enterprises, Inc. (NASDAQ:DXPE), a leading products and service distributor that adds value and total cost savings solutions to MRO and OEM customers in virtually every industry, plans to issue a press release announcing its
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Meilleur Technologies, Inc. today announced a research collaboration agreement with the National Institute of Aging (NIA)-sponsored multicenter study called the Consortium for Clarity in ADRD Research Through Imaging (CL
Pharmaceutical industry leader, Névine Zariffa, to assume new leadership roleNEW YORK--(BUSINESS WIRE)--Leading healthcare technology company Intelligencia AI™ recently appointed pharmaceutical industry leader Névine Zariffa as its Scientific Advisor
North American survey finds consumers and farmers align on the importance of agriculture for a sustainable future, but reveals differing opinions on critical issues such as environmental stewardship and industry advancement.SASKATOON, Saskatchewan--(BUSI
IRVING, Texas--(BUSINESS WIRE)--#FluorBuildsABetterWorld--Fluor Corporation (NYSE: FLR) announced today that its Mining & Metals business has been selected by BHP Canada to develop Stage 2 of its multibillion-dollar Jansen potash project in Saskatchew
- CEO Doug Drysdale to speak on panel about innovations in mental health care on November 7, 2023 -TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin”), a clinical-stage biopharmaceutical company committed to revolutionizing
New data from AbCellera’s T-cell engager platform demonstrates that diverse CD3-binding antibodies enable optimization of T-cell engager function beyond what is possible by modifying a single CD3-binder VANCOUVER, British Columbia--(BUSINESS WIRE)--$A
Dr. Waylon Hunt took an unusual path to co-founding and leading a lab-based business, Intrinsic Analytics.
With a burgeoning scientific portfolio showing a unique ability to boost Akkermansia and Bifidobacteria levels, new products launching before the end of 2023, and international regulatory approvals, Solnul resistant starch “is primed to further penetrate
ElevateIP is a program funded by the Government of Canada aimed at equipping and supporting Canadian start-ups with the tools and knowledge to understand, strategize, protect, manage and leverage their intellectual property (IP)
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.